Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 12INDUSTRY 6NIH 2NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Leukemia 10Leukemia, Biphenotypic, Acute 6Lymphoma 5Burkitt Lymphoma 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myeloid, Acute 3Leukemia, Myelomonocytic, Juvenile 2Dendritic Cell Sarcoma, Interdigitating 2Recurrence 1Prostatic Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Myelodysplastic Syndromes 1Lymphoma, T-Cell 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, T-Cell 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphoid 1Cardiotoxicity 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1Adrenocortical Carcinoma 1

Interventions

bicalutamide 23Radiotherapy 21Goserelin 21Docetaxel 19Flutamide 17Leuprolide 16Prednisone 11Radiotherapy, Conformal 10Gonadotropin-Releasing Hormone 10Radiotherapy, Intensity-Modulated 9Triptorelin Pamoate 8Buserelin 8Estramustine 7Androgen Antagonists 7Brachytherapy 6luprolide acetate gel depot 5enzalutamide 5Paclitaxel 5nilutamide 4darolutamide 4acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 4Radiation 4Mitoxantrone 4Carboplatin 4orteronel 3apalutamide 3Selenium 3Orchiectomy 3Magnetic Resonance Spectroscopy 3Iodine-125 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Prostatic Neoplasms × Hydrocortisone × Clear all
NCT00027859 2023-06-15

Hormone Therapy Compared With Combination Chemotherapy in Treating Patients With Prostate Cancer

Eastern Cooperative Oncology Group

Phase 3 Completed
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡